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Introduction {#sec1}
============

Heart failure (HF) causes high mortality and lack of mobility in developed countries. Currently, heart transplantation is the only radical treatment; however, this treatment approach is limited by donor shortages ([@bib14]). Regenerative medicine represents a promising therapeutic alternative for patients with HF. Human induced pluripotent stem cells (hiPSCs) are an ideal cell source and can be acquired from patient tissues ([@bib24]). Small amounts of cells (graft size: 1.3 × 3 mm^2^, cell density: 4,500 \< viable cells/mm^2^ \< 29,000) have been used for the treatment of macular degeneration in the first clinical application of hiPSCs ([@bib15]). However, more than 1 × 10^9^ hiPSC-derived cardiomyocytes (hiPSC-CMs) would be required to recover cardiac function ([@bib6]).

Although two-dimensional (2D) static culture systems are suitable for both the maintenance and proliferation of hPSCs, most large-scale culture systems for undifferentiated hPSCs have adopted suspension culture systems (SCSs) ([@bib3], [@bib21]). The biggest advantages of SCSs are easy scale-up of culture volume and effortless medium changes. Undifferentiated hPSCs in SCSs experience shear stress from the agitation, resulting in heterogeneity and differentiation and leading to deterioration of cell quality; thus, optimizing agitation speed is necessary for each cell line ([@bib23], [@bib31]). SCSs are more suitable for generation of differentiated cells, as cell aggregation occurs naturally during embryoid body (EB) differentiation ([@bib4], [@bib7], [@bib17]). Methods using microcarriers (MCs) in SCSs are another attractive approach for expansion of hPSCs and CMs ([@bib18]). These SCSs have strong advantages in the scale-up of PSCs and CMs. However, complete elimination of the remaining undifferentiated hPSCs in cell aggregates may not be achieved in SCSs, leading to teratoma formation *in vivo* ([@bib4], [@bib5]).

To eliminate undifferentiated hPSCs from large-scale cultures of hPSC derivatives, [@bib28] developed metabolic purification. Moreover, 2D cell culture is ideal for high-efficiency generation of pure hiPSC-CMs because all cells are evenly exposed to purification medium ([@bib27]).

Here, we report a sequential 2D culture system for the generation of large numbers of pure hiPSC-CMs with high efficiency.

Results {#sec2}
=======

Expansion of hiPSCs in a Single-Layer Culture Plate {#sec2.1}
---------------------------------------------------

We evaluated a large-scale 2D culture system with multilayer culture plates (CPs) and active gas ventilation (AGV) for production of hiPSCs and differentiated CMs. First, hiPSCs (253G4) were passaged in a single-layer CP in a normal gas incubator for 7 days as controls ([Figure 1](#fig1){ref-type="fig"}A). The culture area of the plate was 632 cm^2^, which is more than 11-fold larger than that of a 10-cm dish (55 cm^2^). The proliferation rate was approximately 187-fold ([Figure 1](#fig1){ref-type="fig"}B). Upon inoculation of 1 × 10^6^ hiPSCs, approximately 1.9 × 10^8^ hiPSCs were consistently obtained from a confluent single-layer CP over a 7-day period (3.0 × 10^5^ cells/cm^2^). The karyotype of the cultured hiPSCs was normal ([Figure 1](#fig1){ref-type="fig"}C). The pluripotent state was verified by alkaline phosphatase (AP) staining. All colonies were AP positive, and hiPSCs were evenly cultured throughout the single-layer CP ([Figure 1](#fig1){ref-type="fig"}D). Immunofluorescence staining additionally confirmed strong expression of pluripotency markers in all colonies ([Figure 1](#fig1){ref-type="fig"}E). These data strongly indicated that the present large-scale 2D culture system was suitable for the maintenance of pluripotency in hiPSCs.Figure 1hiPSCs Were Cultured in a Single-Layer CP(A) Schematic representation of the cell culture in a single-layer CP; the total volume of cells in each plate was 120 mL.(B) Growth curve of hiPSCs (253G4) in a single-layer CP. Each dot represents a passage of cells.(C) Karyotype of hiPSCs (253G4) after cell culture in a single-layer CP.(D) Maintenance of hiPSCs (253G4) in the undifferentiated state as determined by alkaline phosphatase staining.(E) hiPSC (253G4) expression of the pluripotency markers TRA1-60, TRA1-81, and SSEA4. Scale bars represent 100 μm.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Expansion of hiPSCs in a Multilayer CP with or without AGV {#sec2.2}
----------------------------------------------------------

Next, hiPSCs (253G4) were cultured in 4-layer CPs with AGV ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The AGV system enabled the maintenance of 5% carbon dioxide (CO~2~) in every layer of a 4- or 10-layer CP. When 4 × 10^6^ hiPSCs were seeded in a 4-layer CP, the number of hiPSCs increased by 179-fold over a 7-day period ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The proliferation efficiency in a 4-layer CP with AGV was almost equal to that of a single-layer CP ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Pluripotency was also confirmed by immunofluorescence staining of NANOG, OCT4, TRA1-60, and SSEA4 ([Figure S1](#mmc1){ref-type="supplementary-material"}D). To evaluate the differences between AGV and normal gas ventilation (NGV), we measured the bioprofiles (partial pressure of CO~2~ \[pCO~2~\], partial pressure of O~2~ \[pO~2~\], pH, glucose, and glutamine) in the culture medium in 4-layer CPs under AGV or NGV ([Figure S1](#mmc1){ref-type="supplementary-material"}E). pCO~2~ was stable at each time point under AGV; however, it significantly increased with time under NGV. pH decreased under both conditions. pO~2~ was not significantly changed, whereas glucose and glutamine remarkably decreased in hiPSC cultures over time, as reported previously ([@bib28], [@bib27]).

Finally, hiPSCs (253G4) were cultured in 10-layer CPs with AGV ([Figure 2](#fig2){ref-type="fig"}A). First, we examined the feasibility of 10-layer CPs with the AGV system. To examine the permeation of CO~2~ in each layer, we observed changes in phenol red color in medium over time. Phenol red in PBS rapidly turned from red to yellow after 1 hr in the AGV system ([Figure 2](#fig2){ref-type="fig"}B). Next, the gas exchange rate was examined using nitrogen filling. The exchange of air was almost completed in 4 hr using the AGV system ([Figure S2](#mmc1){ref-type="supplementary-material"}A). However, gas exchange could not be completed using the NGV system, even over a 24-hr period ([Figure S2](#mmc1){ref-type="supplementary-material"}B). The proliferation efficiency was also compared between NGV and AGV incubators. The proliferation of hiPSCs with AGV was more stable than that with NGV ([Figure 2](#fig2){ref-type="fig"}C). With AGV, the yield was 1.7 × 10^9^ hiPSCs (44% more than under NGV conditions) in the 10-layer CPs over a 7-day period ([Figure 2](#fig2){ref-type="fig"}D). Furthermore, the morphology of hiPSCs was normal, and cells were clearly stained with OCT4, NANOG, SSEA4, and TRA1-60 ([Figure 2](#fig2){ref-type="fig"}E). The expression of pluripotent markers was also confirmed by flow-cytometry analysis ([Figure S2](#mmc1){ref-type="supplementary-material"}C). The differences between AGV and NGV in 10-layer CPs were also compared using bioprofiles ([Figure 2](#fig2){ref-type="fig"}F). Even in the 10-layer CPs, pCO~2~ was more stable at each time point under AGV; however, it was much lower at day 3 and significantly increased with time under NGV. pH decreased under both conditions in the same way as it did in the 4-layer CPs. Unlike in the 4-layer CPs, pO~2~ significantly decreased under NGV conditions. Bioprofiles in 10-cm dishes confirmed that pCO~2~ in multilayer CPs under AGV was as stable as in ordinary cell culture. Moreover, pO~2~ was more stable in multilayer CPs ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}D). These results indicated that AGV was necessary to culture hiPSCs efficiently in multilayer CPs.Figure 2The 10-Layer CP System Was Useful for Acquisition of Large Numbers of hiPSCs(A) Schematic representation of cell culture in a 10-layer CP under active gas ventilation (AGV); the total volume of medium was 1,200 mL per 10-layer CP.(B) Rapid conversion of phenol red in the PBS from red to yellow color over a 1-hr period in the AGV system.(C) Growth curves of hiPSCs (253G4) in a 10-layer CP under normal gas ventilation (NGV, black) or AGV (red). Each dot represents the average cumulative cell numbers in each passage.(D) Proliferation rates in 10-layer CPs under NGV (n = 4) or AGV (n = 4). Each bar represents the average of the fold changes from individual passages.(E) hiPSC (253G4) expression of the pluripotency markers NANOG, OCT4, TRA1-60, and SSEA4, as determined by immunofluorescence staining. Scale bars represent 100 μm.(F) pCO~2~, pO~2~, and pH levels during cultivation in a 10-layer CP under NGV or AGV (n = 3 independent experiments).Data are presented as mean ± SD. ^∗^p \< 0.05; ^∗∗^p \< 0.01. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Cardiac Differentiation from hiPSCs in a Multilayer CP with or without AGV {#sec2.3}
--------------------------------------------------------------------------

hiPSCs (253G4, 201B7, and FfI14) were sequentially differentiated into CMs from 90% confluent hiPSCs in 4- or 10-layer CPs ([Figure 3](#fig3){ref-type="fig"}A). The hiPSC-CMs started to beat at 7--10 days. Cells were collected at day 10 and analyzed by immunofluorescence staining and flow cytometry. Cell viabilities after cardiac differentiation in single-, 4-, or 10-layer CPs under NGV or AGV were over 95% ([Figure 3](#fig3){ref-type="fig"}B). Total cell numbers after differentiation derived from hiPSCs (253G4) in single-, 4-, or 10-layer CPs under AGV were 1.5 × 10^8^, 6.7 × 10^8^, and 1.5 × 10^9^, respectively ([Figures 3](#fig3){ref-type="fig"}C, [S3](#mmc1){ref-type="supplementary-material"}A, and S3B). Total cell number after differentiation derived from other cell lines (201B7 and FfI14) in a 4-layer CP was 6.2--7.0 × 10^8^ ([Figure S3](#mmc1){ref-type="supplementary-material"}B). The cardiac differentiation efficiency (253G4 and FfI14) was not significantly different in 10-layer CPs between AGV and NGV ([Figures 3](#fig3){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}C). In contrast, total hiPSC-CM numbers were higher in AGV than in NGV because proliferative efficiency in lower chambers of 10-layer CPs was low ([Figures 3](#fig3){ref-type="fig"}D, [S3](#mmc1){ref-type="supplementary-material"}C, and S3D). The proportion of cardiac troponin T (cTnT)-positive cells derived from hiPSCs (253G4) using 10-layer CPs was approximately 80% ([Figure 3](#fig3){ref-type="fig"}E). The differentiated CMs were then enzymatically dissociated and seeded on single-layer CPs or 15-cm dishes. Next, the cells were metabolically selected under glucose- and glutamine-depleted and lactate-supplemented conditions ([@bib27]). Expression of the cardiac marker α-actinin was confirmed by immunofluorescence staining ([Figures 3](#fig3){ref-type="fig"}F, 3G, and [S3](#mmc1){ref-type="supplementary-material"}E). Flow-cytometry analysis confirmed that following this metabolic selection, almost all cells (\>97%) clearly expressed cTnT ([Figures 3](#fig3){ref-type="fig"}H, [S3](#mmc1){ref-type="supplementary-material"}F, and S3G; [Movie S1](#mmc2){ref-type="supplementary-material"}). The yield-based efficiency by metabolic selection was 77.5% ([Figure S3](#mmc1){ref-type="supplementary-material"}H), and the viability of the cryopreserved cells after thawing was over 80% ([Figure S3](#mmc1){ref-type="supplementary-material"}I).Figure 3Large-Scale Culture of Cardiac Differentiation from hiPSCs in a Multilayer CP(A) Schematic representation of the cardiac differentiation protocol. The expanded hiPSCs were successively cultured for cardiac differentiation in 4- or 10-layer CPs. d, day; FBS, fetal bovine serum.(B) The bar graphs show cell viability after cardiac differentiation from hiPSCs (253G4) in single-layer (n = 5), 4-layer (n = 7), or 10-layer (n = 5) CPs under NGV or AGV. Data were obtained from independent experiments.(C) Total cell number of hiPSC (253G4)-derived cells in single-layer (n = 5), 4-layer (n = 8), or 10-layer (n = 5) CPs under NGV or AGV. Data were obtained from independent experiments.(D) The proportion and final yield of troponin T-positive cardiomyocytes (CMs) derived from hiPSCs (253G4) in 10-layer CPs under NGV or AGV (n = 5 independent experiments). N.S., not significant.(E) Representative flow-cytometry analysis for troponin T-positive cells in 10-layer CPs under AGV.(F and G) Representative immunofluorescence staining for α-actinin (green) and nuclei (blue) in hiPSC (253G4)-derived dispersed cells before (F) and after (G) metabolic selection. Scale bars represent 500 μm.(H) Representative flow-cytometry analysis for troponin T-positive cells after metabolic selection.Data are presented as mean ± SD. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Characterization of Metabolically Purified hiPSC-CMs {#sec2.4}
----------------------------------------------------

The characteristics of pure hiPSC-CMs via cryopreservation were analyzed by immunostaining. Most hiPSC-CMs developed into the myosin light chain 2v (MLC2v)-positive ventricular phenotype after metabolic selection ([Figure 4](#fig4){ref-type="fig"}A). Electrophysiological characteristics of pure hiPSC-CMs were analyzed by the whole-cell patch-clamp technique and multielectrode array system. The typical action potential of ventricular CMs was recorded, and the results of maximum diastolic potential, action potential amplitude, and action potential duration at 50% of the amplitude supported the ventricular phenotype of pure hiPSC-CMs ([Figures 4](#fig4){ref-type="fig"}B and 4C). To assess functional properties, we added isoproterenol to stimulate β-adrenoceptor ([Figure 4](#fig4){ref-type="fig"}B). The beating rate increased in a concentration-dependent manner ([Figures 4](#fig4){ref-type="fig"}D and 4E). Addition of E-4031 (a water-soluble hERG channel blocker) to pure hiPSC-CMs prolonged field potential duration, a surrogate marker for QT-interval ([Figures 4](#fig4){ref-type="fig"}F and 4G). These data confirmed that pure hiPSC-CMs via cryopreservation had normal electrophysiological properties.Figure 4Electrophysiological Properties of Purified hiPSC-CMs(A) Immunofluorescence staining for α-actinin (red), MLC2v (green), and nuclei (blue) in purified hiPSC (253G4)-CMs after thawing. Scale bars represent 100 μm.(B) Metabolically purified CMs after thawing showed ventricular-like action potentials (n = 4 independent experiments) and responded to isoproterenol (10 nM) administration.(C) The bar graphs show maximum diastolic potential (MDP), action potential amplitude (APA), and action potential duration at 50% of the amplitude (APD50) in metabolically purified CM after thawing (n = 4 independent experiments). Data are presented as mean ± SEM.(D) Representative field potentials (FPs) in metabolically purified CMs with or without isoproterenol administration.(E) The graph summarizes changes in beating rates with or without isoproterenol administration (n = 4 independent experiments). Data are presented as mean ± SD.(F) Representative FPs in metabolically purified CM with or without E4031 administration.(G) The graph summarizes changes in corrected field potential duration (FPD) with or without E4031 administration (n = 4 independent experiments). Data are presented as mean ± SD.^∗^p \< 0.05; ^∗∗^p \< 0.01.

Discussion {#sec3}
==========

A serial large-scale cell culture system using multilayer CPs with AGV was established for hiPSCs and differentiated CMs. A clinically necessary number of hiPSC-CMs was efficiently obtained from both 4- and 10-layer CPs. Finally, the cells were refined by metabolic selection.

Although the cardiac differentiation protocol was reformed, the cardiac differentiation efficiency from hiPSCs depends on the cell line, and such procedures often produce hiPSC-CMs with low efficiency ([@bib16]). Moreover, hiPSC-CMs exhibit a fetal phenotype and gradually lose proliferative capacity after cardiac differentiation over time ([@bib30]). Therefore, the large number of hiPSCs present is a major premise for obtaining hiPSC-CMs on a large scale.

In previous studies, 2D monolayer culture was established as a conventional culture system for undifferentiated hPSCs ([@bib24], [@bib25]). This standard culture method has the advantage of maintaining the pluripotent state and high differentiation potential. Moreover, 2D monolayer culture is also advantageous for cardiac differentiation because all cells are uniformly exposed to medium, including growth factors, small molecules, and paracrine factors ([@bib13], [@bib16]). The main disadvantage of 2D culture systems is low cell yield due to the limited surface area. Thus, 2D culture systems usually need "scale out" to acquire large amounts of cells; this necessitates substantial space and labor ([@bib6]). Multilayer CPs overcame these problems ([@bib20]), but it was difficult to maintain the CO~2~ concentration in each layer evenly in NGV. Fluctuation of CO~2~ concentration could affect cell behavior; highly elevated CO~2~ levels cause mitochondrial dysfunction and impair cell proliferation regardless of acidosis ([@bib29]). Recently, it was reported that mitochondrial oxidative phosphorylation played an important role in survival and proliferation of hiPSCs as well as hiPSC-CMs ([@bib27]). Therefore, one reason for the efficient culture of hiPSCs and hiPSC-CMs that we observed using multilayer CPs may be the stable maintenance of pO~2~ and pCO~2~ allowed by AGV.

Other disadvantages of the 2D culture system are cell harvesting and the lack of control of important culture parameters. Cell harvesting is relatively difficult from multilayer CPs in comparison with single-layer CPs. In our experiments, hiPSC recovery from 4-layer CPs was almost same as that of hiPSCs from single-layer CPs ([Figure S1](#mmc1){ref-type="supplementary-material"}C). However, cell recovery in 10-layer CPs with AGV was estimated to be approximately 90% ([Figures S1](#mmc1){ref-type="supplementary-material"}C and [2](#fig2){ref-type="fig"}D). The total cell yield of 10-layer CPs outweighed this cell loss; however, this problem should be addressed in future studies to improve efficiency. Monitoring of culture conditions is also necessary in future studies of large-scale 2D culture systems using multilayer CPs.

The scalable culture system for hPSCs was mainly researched using SCSs ([@bib3], [@bib8], [@bib22]). The shear stress caused by agitation can affect both pluripotency of hiPSCs and differentiation potential. If spheroid-formed hPSCs in SCSs are not maintained appropriately, they are at high risk of losing pluripotency and developing into EBs ([@bib8], [@bib23]). Particularly with regard to clinical applications, it would be difficult to evaluate the undifferentiated state by observation of hiPSC morphology.

SCSs for somatic differentiation were more common in hPSC culture and were also effective for cardiac development ([@bib4], [@bib7], [@bib17]). When stirred conditions (agitation speed, impeller type, cell density) are appropriately adjusted, cells are easily scaled up, and culture conditions can be monitored with a bioreactor ([@bib7], [@bib19]). However, there is a high possibility that residual undifferentiated hPSCs exist in the EBs. We developed a metabolic selection system with glucose- and glutamine-depleted as well as lactate-supplemented conditions for expansion of clinical-grade hiPSC-CMs ([@bib27]). For clinical applications, the remaining hPSCs in EBs are much more difficult to completely eliminate during purification because they stick to each other, and the purification medium may not reach the cells on the inside of the clumps. If cell aggregates are forced to dissociate, they lose the viability. In contrast, cardiac differentiation in 2D culture was efficient and made it easier to observe cellular status and achieve purification.

MCs are another unique large-scale culture system providing sufficient surface area for cell adhesion in SCSs. MCs were used in static conditions and applied to stirred SCSs ([@bib18]). Recently, serum-free and xeno-free SCSs with MCs also became available ([@bib1], [@bib9]). Despite using MCs, some PSC lines exhibit unavoidable shear stress in stirred SCSs ([@bib12]). Lower shear stress results in highly efficient cardiac differentiation ([@bib26]). MC type, aggregation size, and MC coating are also important for scalable expansion and controlled differentiation of hPSCs ([@bib10], [@bib11]). Cost-effective, xeno-free, and synthetic, dissolvable MCs using non-proteolytic enzymes must be developed for clinical translation ([@bib2], [@bib3]).

In summary, an efficient scalable 2D culture system was developed for the serial culture of undifferentiated hiPSCs until cardiac differentiation. Furthermore, the metabolic selection system enabled successful purification of the expanded hiPSC-CMs. This innovative massive culture system will be useful for generating a large number of hiPSC-CMs with high efficiency for clinical applications.

Experimental Procedures {#sec4}
=======================

Measurement of pCO~2~, pO~2~, pH, and Metabolites in Culture Medium {#sec4.1}
-------------------------------------------------------------------

Under AGV and NGV, pCO~2~, pO~2~, pH, glucose, and glutamine levels in the medium were measured using a BioProfile 400 Analyzer (Nova Biomedical, USA) during the maintenance and cultivation of hiPSCs using the multilayer CPs or 10-cm culture dishes.
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